Related by context. All words. (Click for frequent words.) 55 idiopathic pulmonary fibrosis IPF 53 Pirfenidone 52 COPD 51 NSCLC 50 multiple myeloma 50 cystic fibrosis CF 50 INSPIRE Trial Phase III 50 relapsed ovarian cancer 50 malignant pleural mesothelioma 49 pirfenidone 49 advanced NSCLC 49 Idiopathic Pulmonary Fibrosis 49 Systemic Lupus Erythematosus SLE 49 Ankylosing Spondylitis 49 Pulmonary Fibrosis PF 49 scleroderma 48 Bronchiectasis 48 interstitial lung diseases 48 AA Amyloidosis 48 neuroendocrine tumors 48 idiopathic pulmonary fibrosis 48 relapsing multiple sclerosis 48 Chronic Lymphocytic Leukemia 48 myelofibrosis 48 Lung Cancer 48 Renal Cell Carcinoma RCC 48 Friedreich Ataxia 47 SSc 47 metastatic melanoma 47 hepatocellular carcinoma HCC 47 AAT deficiency 47 lupus nephritis 47 recurrent GBM 47 FSGS 47 Chronic lymphocytic leukemia 47 prostate cancer CRPC 47 GIST 47 Fibrosis 47 carcinoid cancer 47 pleural mesothelioma 47 Idiopathic Pulmonary Fibrosis IPF 47 Pulmonary Fibrosis 47 pancreatic neuroendocrine tumors 47 PsA 46 MPS VI 46 IRESSA 46 Cystinosis 46 familial ALS 46 myeloma 46 Hervé Hoppenot President 46 Amrubicin 46 gastrointestinal stromal tumors 46 Mantle Cell Lymphoma 46 PEGylated interferon beta 1a 46 cell lung cancer 46 myeloproliferative disorders 46 squamous cell lung cancer 46 acute coronary syndrome 46 transthyretin amyloidosis 46 diabetic nephropathy 46 refractory colorectal cancer 46 stage IIIB 46 Psoriasis 46 Aviptadil 46 Gaucher Disease 46 FTY# 46 Parkinson Disease 46 DLBCL 46 secondary hyperparathyroidism 46 AA amyloidosis 46 chronic myeloid 46 haematologic malignancies 46 Acute Myelogenous Leukemia AML 46 pancreatic adenocarcinoma 46 relapsing remitting multiple sclerosis 46 neovascular AMD 46 hematologic disorders 45 acute myeloid 45 IV NSCLC 45 metastatic renal cell carcinoma 45 Myelodysplastic Syndrome MDS 45 systemic fungal infections 45 Tavocept 45 HER2 positive breast cancer 45 metastatic malignant melanoma 45 Multiple Sclerosis 45 Kidney Cancer 45 noninfectious uveitis 45 soft tissue sarcoma 45 severe oral mucositis 45 Critical Limb Ischemia CLI 45 systemic lupus erythematosus 45 advanced hepatocellular carcinoma 45 Age Related Macular 45 Duchenne Muscular Dystrophy 45 lung cancer 45 Malignant Mesothelioma 45 ALS 45 ankylosing spondylitis AS 45 T2DM 45 Myelodysplastic Syndromes 45 metastatic prostate cancer 45 CTCL 45 SJIA 45 Cholangiocarcinoma 45 interstitial pneumonia 45 ALS Amyotrophic Lateral Sclerosis 45 Crohn disease 45 malignant pleural effusion 45 Amyotrophic Lateral Sclerosis ALS 45 Pancreatic Cancer 45 metastatic cancer 45 Acute Myeloid Leukaemia AML 45 Idiopathic pulmonary fibrosis 45 Acute myeloid leukemia 45 relapsed leukemia 45 Primary Immunodeficiency 45 EORTC 45 Gastric cancer 45 Myelofibrosis 45 TEMODAL 45 YONDELIS R 45 CIPN 45 peripheral arterial disease 45 biliary tract cancer 45 malignant pleural mesothelioma MPM 44 carcinoid tumors 44 recurrent NSCLC 44 pulmonary hypertension PH 44 adult chronic ITP 44 ISTH 44 Chronic Fatigue Syndrome CFS 44 Acute Renal Failure 44 CLL 44 acute coronary syndromes ACS 44 Acute Myeloid Leukemia AML 44 myelodysplastic syndromes 44 LEMS 44 paroxysmal atrial fibrillation 44 Actimmune ® 44 soft tissue sarcomas 44 palifosfamide 44 amifampridine phosphate 44 1 Antitrypsin Deficiency 44 efalizumab 44 LHON 44 Acute Heart Failure 44 Safinamide 44 aortic stenosis 44 Myelodysplastic syndromes MDS 44 Haemophilia 44 inoperable pancreatic cancer 44 gastric cancers 44 ProLindac TM 44 OPAXIO 44 Systemic Lupus Erythematosus 44 hepatocellular cancer 44 ADHF 44 Parkinson Disease PD 44 T1D 44 EGFR mutation positive 44 drug zotarolimus 44 pulmonary arterial hypertension PAH 44 Multiple Myeloma 44 diastolic heart 44 Cell Lung Cancer 44 GCSF 44 metastatic carcinoid 44 Heart Failure 44 Duchenne Muscular Dystrophy DMD 44 Neovascular Age Related Macular 44 invasive aspergillosis 44 sJIA 44 choroidal vasculopathy 44 Malignant Melanoma 44 ARC# [001] 44 RhuDex ® 44 ECTRIMS 44 IFN beta 44 Severe Sepsis 44 Hemophilia B 44 Aplidin 44 RSR# 44 Waldenstrom 44 Natalizumab 44 SNT MC# 44 SNT-MC#/idebenone 44 FRDA 44 metastatic colorectal cancer 44 GW# [003] 44 Soft Tissue Sarcoma 44 angiogenesis inhibition 44 HCV infection 44 HeFH 44 RRMS 44 severe aortic stenosis 44 NOMID 44 ASSERT 44 AChE inhibitors 44 Duchenne muscular dystrophy 44 trabectedin 44 Yondelis ® 44 Rheumatoid Arthritis 44 Cancer EORTC 44 cachexia 43 Evoltra 43 Adenoid Cystic Carcinoma 43 Hepatocellular Carcinoma HCC 43 Chronic Lymphocytic Leukemia CLL 43 atherothrombotic 43 Rheumatoid Arthritis RA 43 Fibromyalgia Syndrome 43 Advanced Renal Cell 43 Orphan Drug 43 Systemic Sclerosis 43 HCV infected 43 carcinoid 43 CTEPH 43 heterozygous FH 43 essential thrombocythemia ET 43 Acute MI 43 Kemal Malik 43 cholangiocarcinoma 43 CZP 43 chronic myocardial ischemia 43 brain metastases 43 chronically debilitating 43 recurrent glioblastoma multiforme 43 severe sepsis 43 Myelodysplastic Syndrome 43 Relapsing Remitting MS 43 vascular disrupting agent 43 Chronic Myeloid Leukaemia 43 lorvotuzumab mertansine 43 Lymphoma 43 beta 1a 43 superficial bladder cancer 43 unresectable liver cancer 43 BCIRG 43 VWD 43 riociguat 43 diabetic gastroparesis 43 refractory angina 43 atrial fibrillation AF 43 Hazard Ratio 43 Acute Promyelocytic Leukemia 43 lupus 43 Behcet disease 43 myelodysplastic syndrome 43 leukemia ALL 43 rheumatic diseases 43 pemphigus 43 acute decompensated heart 43 stable angina 43 Wet AMD 43 malignant lymphomas 43 castrate resistant prostate cancer 43 imatinib resistance 43 Congenital Emphysema 43 renal cell carcinoma 43 Alzheimers Disease 43 basal cell carcinoma BCC 43 SUTENT ® 43 Chronic Myeloid Leukemia CML 43 refractory AML 43 leukemia CLL 43 Inflammatory Bowel Disease 43 Peripheral artery disease 43 myelofibrosis polycythemia vera 43 optica 43 pan HDAC inhibitor 43 axitinib 43 bone metastasis 43 StemEx R 43 hematologic malignancies 43 myelodysplastic syndromes MDS 43 tafamidis 43 benign prostatic hyperplasia BPH 43 VHL 43 pancreatic carcinoma 43 Bronchitol 43 HoFH 43 Gefitinib 43 metastatic RCC 43 Myelodysplastic syndrome 43 lung fibrosis 43 natalizumab 43 TG MV 43 relapsed refractory multiple myeloma 43 Fibromyalgia syndrome 43 anti angiogenic therapy 43 Carcinoma 43 Severe Primary IGFD 43 Diasome 43 DHF 43 Fc fusion protein 43 Dual Antiplatelet Therapy 43 vismodegib 43 BioNumerik 43 Atherosclerosis 43 debilitating autoimmune 43 Hepatocellular Carcinoma 43 choroidal neovascularization 43 geographic atrophy 43 depsipeptide 43 lymphoma CTCL 43 orphan medicinal product 43 Pemetrexed 43 Inhaled AAT 43 aortic valve stenosis 43 Apaziquone 43 prostate cancer CaP 43 hepatitis C HCV 43 Pulmonary fibrosis 43 Allergic Rhinitis 43 patientswith 43 BioMatrix 43 Vidaza azacitidine 43 medullary thyroid cancer 43 cell carcinomas 43 Ambrisentan 43 erythropoietin stimulating agents 43 NOXAFIL 43 occlusive disease 43 coinfected patients 43 metastatic neuroendocrine tumors 43 acute promyelocytic leukemia 43 SIR Spheres 43 Nexavar tablets 43 motor neuron diseases 43 systemic lupus erythematosus SLE 43 Diabetic nephropathy 43 nonsmall cell lung cancer 43 myotonic muscular dystrophy 43 Pulmonary arterial hypertension 43 Troxatyl 43 ADPKD 43 COPAXONE R 42 AAT Deficiency 42 acute PAO 42 hepatocellular carcinoma 42 fibromyalgia syndrome 42 amrubicin 42 relapsed multiple myeloma 42 chronic HBV infection 42 systemic fungal infection 42 ulcerative colitis UC 42 vandetanib 42 Angiox R 42 palifermin 42 Gleevec resistant 42 CIMZIA TM certolizumab pegol 42 Pulmonary Arterial Hypertension 42 MS 42 Li Fraumeni Syndrome 42 unstable angina pectoris 42 BioImage Study 42 Metastatic Colorectal Cancer 42 Trandolapril 42 BPH 42 hypoparathyroidism 42 EoE 42 OSA 42 Investigational Drug 42 Neuropathy 42 Candesartan 42 squamous cell carcinoma SCC 42 histone deacetylase HDAC inhibitor 42 Diabetes ACCORD 42 refractory multiple myeloma 42 multicenter randomized Phase 42 BCG refractory 42 Lou Gehrigs disease 42 prostate cancer HRPC 42 diabetic macular edema 42 uveitis 42 Movement Disorder 42 acute coronary syndromes 42 metastatic cancers 42 Myocardial Infarction 42 Retinitis Pigmentosa RP 42 cardio renal 42 lupus renal disease 42 Zavesca 42 relapsed SCLC 42 Alzheimers disease 42 sporadic ALS 42 Panzem 42 Huntington Disease 42 acromegaly 42 Simulect 42 Proxinium TM 42 Xanafide 42 Fabry Disease 42 hyperphosphataemia 42 Liver Cancer 42 Sorafenib 42 neuro degenerative disease 42 Morquio 42 recurrent ovarian cancer 42 chronic hepatitis B. 42 HNSCC 42 hormone refractory prostate cancer 42 ankylosing spondylitis 42 multiple myeloma MM 42 SCCHN 42 clazosentan 42 Relapsing Remitting Multiple Sclerosis 42 lymphocytosis 42 Irinotecan 42 leukemia lymphoma Hodgkin 42 HRPC 42 Enzyme Replacement Therapy 42 cangrelor 42 primary immunodeficiency 42 subcutaneous methylnaltrexone 42 UPLYSO 42 Iron Overload 42 GIST tumors 42 membranous nephropathy 42 Duchenne muscular dystrophy DMD 42 Dupuytren contracture 42 phase IIb clinical 42 nephrogenic systemic fibrosis 42 Evoltra ® 42 atherosclerotic disease 42 Myelodysplasia 42 Erythropoietic 42 lung cancers 42 Interstitial Cystitis 42 Ilaris 42 nosocomial pneumonia 42 anti TNF 42 Cachexia 42 gastrointestinal stromal tumors GIST 42 CIMZIA ™ 42 LUMINATE 42 busulfan 42 PAOD 42 hemophilia B. 42 Alzheimer disease AD 42 Adjuvant therapy 42 critical limb ischemia 42 COPAXONE ® 42 everolimus 42 idiopathic pulmonary arterial hypertension 42 Chronic Myelogenous Leukemia CML 42 PRoFESS 42 tipranavir 42 ATTR 42 Ataluren 42 Ceflatonin R 42 metastatic colon cancer 42 atypical Hemolytic Uremic Syndrome 42 Temsirolimus 42 progressive neurodegenerative disorder 42 mRCC 42 decompensated heart failure 42 MELAS 42 Liver Disease 42 unresectable 42 pheochromocytoma 42 Acute Coronary Syndromes ACS 42 orphan designation 42 Psoriatic Arthritis 42 Aspergillosis 42 ISEL 42 smoldering myeloma 42 homozygous FH 42 Glivec 42 disease COPD 42 fibrotic disease 42 CML 42 liver metastases 42 acute myelogenous leukemia AML 42 Myeloma 42 colorectal cancer CRC 42 tyrosine kinase inhibitors TKIs 42 Thrombotic 42 Leber Congenital Amaurosis LCA 42 Celgene Revlimid 42 Mucopolysaccharidosis 42 anaplastic thyroid cancer 42 Akt inhibitor 42 sunitinib malate 42 FTLD 42 Voreloxin 42 relapsing MS 42 recurrent glioblastoma 42 Esbriet 42 lumbar spinal stenosis LSS 42 biliary cancer 42 refractory metastatic colorectal cancer 42 chronic ITP 42 mCRC 42 Phenoptin 42 Atypical Hemolytic Uremic Syndrome 42 Parkinsons disease 42 primary immunodeficiency PI 42 stage IIIB IV 42 Fx #A 42 Papillary 42 stage IIIb IV 42 A1PI 42 Sarcoidosis 42 bevacizumab 42 bronchiectasis 42 SWOG 42 pouchitis 42 familial amyloidotic polyneuropathy FAP 42 ACCORD Lipid 42 unresectable stage 42 liver transplant recipients 42 metastatic colorectal carcinoma 42 CTAP# Capsules 42 Raptiva R 42 ToGA 41 metastatic bone 41 immune thrombocytopenic purpura ITP 41 psoriasis 41 neurological manifestations 41 Leber Hereditary Optic Neuropathy 41 Cancer Gene Therapy 41 Acute Myocardial Infarction AMI 41 carcinoma 41 NMO 41 VaD 41 OLYMPIA registry 41 refractory GIST 41 Hypoparathyroidism 41 interferon beta therapy 41 Neuropathic Pain 41 chronic ITP patients 41 Glioblastoma Multiforme 41 PIDD 41 Myelodysplastic Syndromes MDS 41 BIM #A# 41 Cloretazine 41 EPDA 41 Melanoma 41 thromboembolic 41 vertebral compression fractures 41 anti fibrotic 41 metastatic lung cancer 41 Atrial Fibrillation 41 glioblastoma 41 Cardiomyopathy 41 hematological malignancy 41 chemoresistance 41 Waldenstrom Macroglobulinemia 41 Cutaneous T 41 Prolor 41 Dalbavancin 41 ACUITY trial 41 MGUS 41 opioid induced constipation OIC 41 Sezary syndrome 41 Romiplostim 41 cutaneous melanoma 41 EndoTAGTM 1 41 gastroesophageal junction 41 Chronic Kidney Disease 41 Chronic Myeloid Leukemia 41 myeloproliferative diseases 41 metastatic bladder 41 gastric cancer 41 allogeneic hematopoietic stem cell 41 Acute renal failure 41 virus HCV 41 Gastrointestinal Oncology 41 leukemia AML 41 neurogenic orthostatic hypotension 41 Metastatic breast cancer 41 Severe Asthma 41 dilated cardiomyopathy DCM 41 immunocompromised patients 41 hepatorenal syndrome 41 colorectal carcinoma 41 IL# PE#QQR 41 metastatic renal cell 41 chronic myeloid leukemia CML 41 Diabetic Macular Edema 41 acute exacerbation 41 EndoTAG TM -1 41 hematopoietic cell 41 cardiac dysfunction 41 metastatic disease 41 Respiratory Viral Infections 41 SHPT 41 Rotigotine 41 systemic scleroderma 41 Burkitt Lymphoma 41 nasopharyngeal carcinoma 41 Granulocyte Colony Stimulating Factor 41 spondyloarthritis 41 hypophosphatasia 41 pancreatic cancers 41 metastatic malignant 41 myeloproliferative neoplasms 41 Tuberous Sclerosis 41 vidofludimus 41 acute leukemia AML 41 curative therapy 41 Rilonacept 41 AML 41 Dr. McHutchison 41 malignant mesothelioma 41 Medidur ™ FA 41 Renal 41 alpha1 antitrypsin AAT deficiency 41 colorectal liver metastases 41 Occlusive Disease 41 HCV 41 GISTs 41 colorectal cancer 41 MPGN 41 ESMO 41 Scleroderma 41 Cardiology ESC 41 Seliciclib 41 benign prostatic hypertrophy BPH 41 vorinostat 41 chronic granulomatous disease 41 Nephrotic Syndrome 41 ESRD 41 Daclizumab 41 aclidinium bromide 41 nasopharyngeal cancer 41 solid tumors 41 atrial fibrillation 41 Actemra 41 HIF PHI 41 acute bacterial sinusitis 41 vWD 41 bendamustine 41 Chronic Renal Failure 41 somatostatin analogues 41 neurologic progression 41 Adenocarcinoma 41 mildly symptomatic 41 Cancer AACR NCI 41 Amyloid 41 psoriatic arthritis PsA 41 lumiliximab 41 PD LID 41 diabetic macular edema DME 41 ADHERE 41 Renal Cancer 41 metastatic breast cancer 41 bone metastases 41 antiproliferative effects 41 adrenocortical carcinoma 41 ADVEXIN therapy 41 BCR ABL inhibitor 41 chronic lymphocytic leukemia CLL 41 RVO 41 metastatic colorectal 41 SSc patients 41 Evoltra TM 41 Aryplase 41 Follicular Lymphoma 41 papillary renal cell carcinoma 41 HYCAMTIN 41 Dr Parag Sancheti 41 Alzheimer Disease 41 percutaneous transluminal coronary angioplasty 41 Glivec imatinib 41 eprotirome 41 gastrointestinal stromal tumor GIST 41 HIBM 41 cell carcinoma 41 Ischemia 41 CFS ME 41 Benign Prostatic Hyperplasia BPH 41 metastatic hormone refractory 41 afamelanotide 41 Elvitegravir 41 PKC# 41 oropharyngeal candidiasis 41 rheumatic disease 41 smoldering multiple myeloma 41 diabetic kidney 41 ENDEAVOR IV 41 abiraterone 41 postoperative ileus 41 EURORDIS 41 cell lymphoma CTCL 41 metastatic uveal melanoma 41 lymphocytic leukemia 41 intermittent claudication 41 Spinal Muscular Atrophy SMA 41 ZACTIMA 41 paroxysmal nocturnal hemoglobinuria PNH 41 chimeric monoclonal antibody 41 Etanercept 41 ONTARGET R 41 Afib 41 PROVENGE 41 GammaCan 41 tocilizumab 41 Val HeFT 41 immunomodulatory therapy 41 Arcalyst 41 Orphan Medicinal Product 41 pancreatic insufficiency 41 fibrotic disorders 41 Ischemic 41 thymoma 41 Research CAMR 41 Can Fite 41 pulmonary exacerbations 41 Lupus 41 Cladribine Tablets 41 Pancreatic 41 Dasatinib 41 purpura 41 ximelagatran 41 small molecule activators 41 transplantation HSCT 41 psoriasis psoriatic arthritis 41 Genz # 41 Bcr Abl T#I mutation 41 Motor Neuron 41 carcinoid syndrome 41 Acute Coronary Syndrome 41 mycophenolate mofetil 41 myelodysplastic syndrome MDS 41 ischemic cardiomyopathy 41 Pandithan 41 microtubule associated 41 prostate cancer AIPC 41 retinal pigment epithelium RPE 41 NLX P# 41 renal anemia 41 metastatic gastric 41 panobinostat 41 RLS 41 multikinase inhibitor 41 unoprostone isopropyl 41 anorexia cachexia 41 Catena ® 41 neuroendocrine cancers 41 YONDELIS 41 relapsed CLL 41 idiopathic myelofibrosis 41 proliferative diabetic retinopathy 41 ST Segment Elevation 41 Factor VIIa 41 amyotrophic lateral sclerosis ALS 41 PNH 41 chronic myelogenous leukemia CML 41 Benign Prostatic Hypertrophy 41 pancreatic islet cell 41 micrometastases 41 Factor Xa inhibitors 41 IGF 1R inhibitor 41 ALS MND 41 Chronic myeloid leukemia 41 isolated systolic hypertension 41 castration resistant prostate cancer 41 Hematologists 41 HepaSphere 41 investigational therapies 41 OX1 41 chemoresistant 41 ADVEXIN 41 OXIGON TM 41 essential thrombocythemia 41 NMIBC 41 pulmonary fibrosis 41 NAFLD 41 Liver transplantation 41 ATTR PN 41 Angiotensin II 41 dyskeratosis congenita 41 pancreatic NET 41 Hematologic 41 CRVO 41 Oral Mucositis 41 NYHA Class II 41 CVBT #H 41 Gleevec Glivec 41 Chronic HCV infection 41 ponatinib 41 chemotherapeutic regimen 41 pulmonary embolism PE 41 Tyrosine Kinase Inhibitors 41 CKD 41 Eliezer Zomer Ph.D. 41 Sjogren Syndrome 41 canakinumab 41 Transthyretin 41 GRASPA ® 41 RE LY 41 antithrombotic 41 atherothrombosis 40 bucindolol 40 Leukemia Lymphoma 40 Bladder Cancer 40 NP2 Enkephalin 40 CCX# B 40 Fibrin Pad 40 VLUs 40 Surgical resection 40 Fabry disease 40 Epirubicin 40 GvHD 40 sargramostim 40 Dilated Cardiomyopathy 40 RTOG 40 atherothrombotic disease 40 incurable neurodegenerative disease 40 subcutaneous formulation 40 gastric carcinoma 40 ALI ARDS 40 gastrointestinal cancers 40 FOLFIRINOX 40 STRIDE PD 40 Pseudomonas aeruginosa infections 40 Advexin 40 IFN 40 Nexavar sorafenib 40 Duchenne 40 obatoclax 40 prostate adenocarcinoma 40 Schizophrenia 40 neoplastic diseases 40 Progressive Multifocal Leukoencephalopathy 40 pretransplant 40 TRO# 40 cystinosis 40 Lupus Nephritis 40 lymphoproliferative disease 40 nonmelanoma skin cancers 40 Annamycin 40 CYPHER Stent 40 hypereosinophilic syndrome 40 sunitinib 40 saphenous vein graft 40 Cystic Fibrosis 40 interstitial cystitis IC 40 Diamyd ® 40 pulmonary fibrosis PF 40 Symadex 40 retinal diseases 40 vinorelbine 40 IFOS 40 myasthenia gravis MG 40 Lambert Eaton Myasthenic 40 HYVET 40 LUX Lung 40 common hematologic malignancy 40 metastatic CRC 40 Primary IGFD 40 KRAS mutant tumors 40 chronic cerebro spinal 40 seminoma 40 Nilotinib 40 Zarnestra 40 bevacizumab Avastin ® 40 XYOTAX TM 40 RhuDex TM 40 posaconazole 40 NeuroStar TMS Therapy 40 Canvaxin 40 PARP inhibitor 40 AIM HIGH 40 acetonide FA 40 MYDICAR ® 40 Non Hodgkins lymphoma 40 PNET 40 haematological cancers 40 juvenile idiopathic arthritis 40 Relapsing remitting MS 40 esophageal squamous cell carcinoma 40 aHUS 40 Degarelix 40 inherited neurodegenerative disorder 40 lung tumors 40 RNAi therapeutic targeting 40 Renal cell carcinoma 40 fenretinide 40 Diabetes Mellitus 40 familial hypercholesterolemia 40 Early Lung Cancer 40 Gorlin syndrome 40 HuMax CD# 40 ELSO 40 pulmonary arterial hypertension 40 Virulizin R 40 Renal Physicians 40 T#I [002] 40 frontotemporal dementia 40 darinaparsin ZIO 40 predominantly classic subfoveal 40 erythematosus 40 ThGRF 40 mesotheliomas 40 HuMax EGFr 40 cutaneous T cell 40 relapsing remitting 40 Critical limb ischemia 40 registrational trial 40 REACH Registry 40 phase IIa clinical 40 acute myocardial infarction AMI 40 fallopian tube carcinoma 40 Quinamed 40 Community Acquired Pneumonia 40 gemcitabine carboplatin 40 portal vein thrombosis 40 satraplatin Phase 40 adenocarcinoma 40 HIV HCV coinfected 40 mepolizumab 40 Hepsera adefovir dipivoxil 40 ME CFS 40 Castration Resistant Prostate Cancer 40 fulminant 40 Serious Adverse Events 40 systolic hypertension 40 INCB# [003] 40 Doxil ® 40 cancer mCRC 40 Axitinib 40 Alemtuzumab 40 Acute Leukemia 40 Exelixis XL# 40 Tarceva erlotinib 40 nephrogenic fibrosing dermopathy 40 radionuclide therapy 40 ASCO GI 40 fistulizing Crohn disease 40 Elafin 40 Lateral Sclerosis 40 INCB# [002] 40 cladribine 40 undifferentiated arthritis 40 streptokinase 40 TheraSphere 40 Amyloidosis 40 Myasthenia gravis 40 Bapineuzumab 40 Solesta 40 octreotide 40 QVAR R 40 interferon gamma 1b 40 Xinlay 40 Cystic Fibrosis CF 40 rheumatoid arthritis RA 40 CABP 40 intravenous AAT 40 painful diabetic neuropathy 40 IPX# 40 mitral regurgitation MR 40 pulmonary fungal infections 40 invasive lobular carcinoma 40 vasodilators 40 invasive bladder 40 HBeAg negative 40 Refractory Angina 40 hepatic encephalopathy 40 Coronary Artery Disease 40 epithelial tumors 40 IGIV 40 sunitinib Sutent 40 Acute Coronary Syndromes 40 resected pancreatic cancer 40 chronic lymphocytic leukemia 40 demyelinating diseases 40 levosimendan 40 adverse cytogenetics 40 Torisel 40 Targretin 40 cutaneous lupus 40 Liver EASL 40 cancer cachexia 40 eIF 4E 40 StemEx 40 EFNS 40 papillary RCC 40 relapsing forms 40 tanespimycin 40 limb ischemia 40 relapsed AML 40 variceal bleeding 40 non alcoholic steatohepatitis 40 oral FTY# 40 schizophrenia CIAS 40 Velcade bortezomib 40 ExCell study 40 BCG refractory carcinoma 40 gastric lymphoma 40 doxorubicin Adriamycin 40 Pulmonary hypertension 40 chronic hepatitis C. 40 Tacrolimus 40 immunomodulatory agents 40 Nancy Simonian MD